Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma: A Randomized Controlled Trial for Determining the Efficacy of Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization

To improve the efficacy of radiofrequency ablation (RFA) for the treatment of intermediate-sized hepatocellular carcinomas (HCCs), the authors compared RFA combined with transcatheter arterial chemoembolization (TACE) to RFA alone. The authors randomly assigned 37 patients with solitary HCCs (diamet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2010-12, Vol.116 (23), p.5452-5460
Hauptverfasser:	MORIMOTO, Manabu, NUMATA, Kazushi, KONDOU, Masaaki, NOZAKI, Akito, MORITA, Satoshi, TANAKA, Katsuaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Biological and medical sciences Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Catheter Ablation - methods Chemoembolization, Therapeutic - methods Combined Modality Therapy - adverse effects Disease Progression Female Gastroenterology. Liver. Pancreas. Abdomen Humans Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - therapy Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!